Clinical trial
ASSURE WCD Clinical Evaluation - Detection and Safety Study
NCT03887052 · Kestra Medical Technologies, Inc., Industry · Completed
Key facts
| NCT number | NCT03887052 |
|---|---|
| Title | ASSURE WCD Clinical Evaluation - Detection and Safety Study |
| Official title | ASSURE WCD Clinical Evaluation - Detection and Safety Study (ACE-DETECT) |
| Acronym | ACE-DETECT |
| Lead sponsor | Kestra Medical Technologies, Inc., Industry |
| Collaborators | Regulatory and Clinical Research Institute Inc |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cardiac Arrest, Sudden |
| Intervention type | Device |
| Interventions | ASSURE™ Wearable Cardioverter Defibrillator (WCD) |
| Enrollment | 130 |
| Start date | Mar 20, 2019 |
| Primary completion | Jun 18, 2019 |
| Completion | Jun 18, 2019 |
| First posted | Mar 22, 2019 |
| Last update posted | Mar 12, 2024 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: